Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ORA | Common Stock, par value $0.001 per share | Sale | -$279M | -3.7M | -55.42% | $75.38 | 2.98M | Dec 13, 2024 | Direct | F1, F2, F3 |
Orix Corp is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | On December 13, 2024, ORIX Corporation ("ORIX") completed the sale of 3,700,000 of their shares of common stock, par value $0.001 per share ("Shares") of the Issuer pursuant to that certain Underwriting Agreement by and among ORIX, the Issuer and Goldman Sachs & Co. LLC (the "Underwriter"), dated December 11, 2024. The Underwriter has not yet exercised its option to purchase up to an additional 555,000 Shares, which option is exercisable for a period of 30 days after December 11, 2024 ("Over-Allotment Option"). |
F2 | The sales price of $75.38 represents the $76.20 public offering price per Share, less the underwriting discount of $0.82 per Share. |
F3 | In addition to the reported transaction, 555,000 Shares that continue to be held by the Reporting Person are subject to the Over-Allotment Option. |